eprintid: 60502
rev_number: 1
eprint_status: archive
userid: 1
dir: disk0/00/06/05/02
datestamp: 2026-05-26 15:51:44
lastmod: 2026-05-26 15:51:44
status_changed: 2026-05-26 15:51:44
type: article
metadata_visibility: show
sword_depositor: 1
creators_name: Eshmo’minovich, Raimov Kamol
title: PEG-INF ALFA-2B (ALGERON)  VA TENOFOVIR ALAFENAMID (TAF) KOMBINATSIYASINING SURUNKALI DELTA GEPATITNI DAVOLASHDAGI SAMARADORLIGINI BAHOLASH
ispublished: pub
note: Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/14578)
abstract: Surunkali delta gepatit (SDG) – gepatit B virusi (HBV) bilan birgalikda yuquvchi kasallik bo‘lib, jigar to‘qimasida og‘ir yallig‘lanish va fibroz jarayonlarini keltirib chiqaradigan kasallikdir. SDG dunyo bo‘yicha gepatitlar orasida eng xavfli va davolashda murakkab bo‘lgan turlaridan biri hisoblanadi.
date: 2025-11-20
date_type: published
publisher: "Research Science and Innovation house" LLC
official_url: https://universalpublishings.com/index.php/jusr/article/view/14578
id_number: oai:ojs.pkp.sfu.ca:article/14578
full_text_status: none
publication: Journal of Universal Science Research
citation:   Eshmo’minovich, Raimov Kamol  (2025) PEG-INF ALFA-2B (ALGERON) VA TENOFOVIR ALAFENAMID (TAF) KOMBINATSIYASINING SURUNKALI DELTA GEPATITNI DAVOLASHDAGI SAMARADORLIGINI BAHOLASH.  Journal of Universal Science Research.